Renowned Tamil actor Daniel Balaji passes away at 48

Pallavi Madhiraju- March 30, 2024 0

In a sorrowful turn of events, the Tamil film industry has lost one of its celebrated actors, Daniel Balaji, who succumbed to a heart attack ... Read More

Farxiga : AstraZeneca gets FDA fast track status for heart failure after MI

pharmanewsdaily- July 20, 2020 0

AstraZeneca has secured fast track designation for Farxiga (dapagliflozin) in the US for its use in reducing the risk of hospitalization for heart failure (hHF) ... Read More

Lilly bags Trulicity FDA approval for reducing CV risk in type 2 diabetes patients

pharmanewsdaily- February 22, 2020 0

Trulicity FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug Administration (FDA) for Trulicity (dulaglutide) to reduce ... Read More

CytoSorbents gets CytoSorb EU approval for removal of ticagrelor during CPB

pharmanewsdaily- February 9, 2020 0

CytoSorbents has secured approval from the European Union (EU) for its CytoSorb extracorporeal blood purification therapy for the removal of anti-platelet agent ticagrelor during surgery ... Read More

Amarin bags Vascepa FDA approval for reducing cardiovascular risk

pharmanewsdaily- December 16, 2019 0

Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA) for a new indication and label expansion ... Read More

Common signs of heart attack in women not to ignore

pharmanewsdaily- May 23, 2019 0

All knew that chest pain is the common signs of heart attack. In the real life the common symptoms of heart attack include other signs ... Read More

Wayne Pharmaceuticals launches Dr Wayne’s Aspirin in US

pharmanewsdaily- April 27, 2019 0

Wayne Pharmaceuticals has launched Dr Wayne’s Aspirin Tablets in the US in a bottle package containing 300 tablets, each having 81mg strength. Dr. Wayne’s Aspirin ... Read More

Regeneron and Sanofi’s Praluent gets European approval for reducing cardiovascular risk in atherosclerotic disease patients

pharmanewsdaily- March 24, 2019 0

Regeneron Pharmaceuticals and Sanofi have received a significant boost with the European Commission's (EC) approval of Praluent (alirocumab) for a new indication. The approval enables ... Read More

Lycopene Uses for Cardiovascular Diseases | Tomato Health Benefits

pharmanewsdaily- April 20, 2018 1

As per the research done by the scientists of Cambridge Theranostics Ltd, a biotech firm, lycopene pigment present in tomatoes protect us from cardiovascular diseases ... Read More

FDA approves Amgen’s Repatha for heart attack and stroke prevention

pharmanewsdaily- December 9, 2017 0

In a significant advancement for cardiovascular disease management, Amgen's Repatha (evolocumab) has received approval from the U.S. Food and Drug Administration (FDA) to prevent heart ... Read More